Talk:Imiglucerase

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Imiglucerase.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Untitled

Removed unhelpful reference to cost-per-mg. Reasons: (i) Dosage is in IU, not mg. Cost per IU might have been useful; cost per mg is not. (ii) As a general indicator of expense, we already have a far-more-informative statement about the typical cost per patient per year. (iii) Source of this information not cited; format of stated cost ("for a 40kg patient, $3m per mg of enzyme") indicates that this may have been reverse-calculated from the typical cost per year, a hypothesised patient mass, and the molecular weight of the drug, and hence is not a reliable figure. (Cost per mg of enzyme does not exhibit any dependence on patient weight!)

Action: Removed spurious sentence. Added link to article "orphan drug" to provide background on government incentives for the development of unprofitable, but life-changing, medications for rare diseases.

R. Pfeifer, 58.96.54.100 (talk) 11:02, 4 March 2011 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified one external link on Imiglucerase. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20030605012113/http://www.cerezyme.com/global/pi.pdf to http://www.cerezyme.com/global/pi.pdf

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 07:00, 12 November 2017 (UTC)[reply]